Dr John Wilbur Coddington, MD | |
512 Main Street, Hoven, SD 57450-0158 | |
(605) 948-2262 | |
Not Available |
Full Name | Dr John Wilbur Coddington |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 512 Main Street, Hoven, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629082086 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr John Wilbur Coddington, MD Po Box 158, Hoven, SD 57450-0158 Ph: (605) 948-2262 | Dr John Wilbur Coddington, MD 512 Main Street, Hoven, SD 57450-0158 Ph: (605) 948-2262 |
News Archive
iCo Therapeutics Inc., today reported results of its Oral Amphotericin B (Oral Amp B) drug candidate targeting latent HIV reservoirs.
Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the DRIVe (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority, under the Office of the Assistant Secretary for Preparedness and Response, within the United States Department of Health and Human Services.
A plan to reopen Los Angeles' Martin Luther King Jr. hospital as a private, nonprofit facility in partnership with the University of California is the latest example in a new trend among public hospitals that has lead to greater efficiency, and often quality elsewhere, The New York Times reports. Like many public hospitals, MLK had a track record of inconsistent quality and grim finances, and "was closed in 2007 after a series of errors, some of them fatal.
BioSphere Medical, Inc. - the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy - today reported that it has entered into an a definitive agreement and plan of merger with Merit Medical Systems, Inc. and Merit BioAcquisition Co., a wholly-owned subsidiary of Merit Medical pursuant to which BioSphere Medical will merge with and into Merit BioAcquisition Co. in a cash transaction valued at approximately $96 million.
› Verified 3 days ago